WASHINGTON – A new kind of malaria vaccine that mimics the effects of mosquito bites has shown early promise by offering 100 percent protection to a dozen human volunteers, researchers said Thursday. The experimental vaccine, called PfSPZ and produced by the Maryland-based company Sanaria, contains live malaria parasites collected through a painstaking process of dissecting the salivary glands of mosquitoes. These immature parasites, known as sporozoites, are then weakened so they cannot cause illness and incorporated into a vaccine, which must be injected into a person's veins several times, with each shot about a month apart. "When we started do...
Keep on reading: Early promise for malaria vaccine that mimics bug bites
No comments:
Post a Comment